|
Volumn 101, Issue 4, 2005, Pages 168-171
|
Monotherapeutic brachytherapy for clinically organ-confined prostate cancer.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
AGED;
ANALYSIS OF VARIANCE;
ARTICLE;
BLOOD;
BRACHYTHERAPY;
CANCER STAGING;
COHORT ANALYSIS;
COMPUTER ASSISTED RADIOTHERAPY;
FOLLOW UP;
HUMAN;
MALE;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
MULTIVARIATE ANALYSIS;
PATHOLOGY;
PROPORTIONAL HAZARDS MODEL;
PROSTATE TUMOR;
RADIATION DOSE;
RADIATION RESPONSE;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
SURVIVAL;
TREATMENT OUTCOME;
AGED;
ANALYSIS OF VARIANCE;
BRACHYTHERAPY;
COHORT STUDIES;
DOSE-RESPONSE RELATIONSHIP, RADIATION;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
NEOPLASM STAGING;
PROPORTIONAL HAZARDS MODELS;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
RADIOTHERAPY DOSAGE;
RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;
RETROSPECTIVE STUDIES;
RISK ASSESSMENT;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 33644684641
PISSN: 00433284
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (19)
|
References (0)
|